Save the date:
Developing Therapeutics for Alpha-1 Antitrypsin Deficiency Workshop
When: Monday, September 16, 2019
Where: Natcher Conference Center
National Institutes of Health Campus
9000 Rockville Pike
Bethesda, MD 20892
The Food and Drug Administration (FDA) is announcing the following public workshop entitled “Developing Therapeutics for Alpha-1 Antitrypsin Deficiency.” The purpose of the public workshop is to foster the development of therapeutic products for the treatment of alpha-1 antitrypsin deficiency (AAT deficiency).
This event is sponsored by the FDA and the National Institutes of Health (NIH).
Click here for complete information.
Click here to view the full agenda.